title: [Evolution of the neonatal screening program in the state of Tocantins].
abstract: OBJECTIVE
  To evaluate the Neonatal Screening Program in the State of Tocantins from 1995 to 2011.
  
  
  METHODS
  Data collection was conducted by means of interviews with those responsible for the service, by the analysis of medical records of patients diagnosed with phenylketonuria (PKU) and congenital hypothyroidism (CH) that were enrolled in the program, and by interviews with parents and/or guardians of the patients monitored.
  
  
  RESULTS
  Program coverage increased from 32.3% to 76.6% after the implementation of the National Newborn Screening Program (PNTN). The prevalence of PKU and CH was 1:28,309 and 1:4,632 live births, respectively. The mean ages at the collection of the first blood sample (PKU: 9.6 ± 6.3 days; CH: 13.3 ± 10.3 days) and at the beginning of the treatment (PKU: 57.0 ± 17.6 days; CH: 95,6 ± 57.6 days) were greater than recommended by the Ministry of Health. The quality of monitoring was considered satisfactory by 100% of the parents.
  
  
  CONCLUSIONS
  Although there have been great developments in neonatal screening program in this state, there is need for greater government incentives to optimize the program and to make the PNTN advance to its next phases.
authors.affiliation: Faculdade de Ciências Humanas, Econômicas e da Saúde de Araguaína, Instituto Tocantinense Presidente Antônio Carlos (FAHESA/ITPAC), Araguaína, TO, Brasil.
authors.forename: Lucas Corrêa
authors.initials: LC
authors.lastname: Mendes
authors.forename: Taides Tavares dos
authors.initials: TT
authors.lastname: Santos
authors.forename: Fabiana de Andrade
authors.initials: Fde A
authors.lastname: Bringel
mesh_terms: D001938:Brazil / Q000453:epidemiology; D003409:Congenital Hypothyroidism / Q000175:diagnosis* / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009313:National Health Programs; D015997:Neonatal Screening / Q000592:standards*; D010661:Phenylketonurias / Q000175:diagnosis* / Q000453:epidemiology; D015995:Prevalence; D015397:Program Evaluation; D011785:Quality Assurance, Health Care